Another major derailing event for CHM. Lead therapy is now in the clinic….
only a single dose of CDH17 CART is contemplated for each patient for the trial. If we see early efficacy signals and low toxicity during the dose escalation then LOOKOUT!
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-7
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.776M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.73K | 1.077M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 5624045 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 3249484 | 8 |
View Market Depth
| Last trade - 14.35pm 01/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |